<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03635333</url>
  </required_header>
  <id_info>
    <org_study_id>2000023077-2</org_study_id>
    <nct_id>NCT03635333</nct_id>
  </id_info>
  <brief_title>Effects of E-Cigarette Flavors on Adults TCORS 2.0</brief_title>
  <official_title>Effects of E-Cigarette Flavors on Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yale University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yale University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study looks at the effects of flavors when administered with nicotine in e-cigarettes in
      younger and older adult cigarette smokers.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study looks at the effects of flavors when administered with nicotine in e-cigarettes in
      younger and older adult cigarette smokers. Regular cigarette smokers who do not want to quit
      smoking will be asked to complete 3 lab sessions in which they will use an e-cigarette and
      complete questionnaires. This will be followed by a two-week period where participants are
      asked to stop using cigarettes and other tobacco products and to only use the e-cigarettes
      provided. Researchers will examine the influence of flavors (sweet, cool, tobacco) on reward
      (liking/wanting) from e-cigs containing one of two nicotine concentrations (6 mg/ml, 18
      mg/ml) following acute tobacco abstinence.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 15, 2019</start_date>
  <completion_date type="Anticipated">February 2024</completion_date>
  <primary_completion_date type="Anticipated">August 2023</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change score in liking/wanting of e-cigarette</measure>
    <time_frame>Baseline (+10 minutes) to end of lab session (+40 minutes)</time_frame>
    <description>The Labeled Hedonic Scale (LHS; Lim et al., 2009) will be used to ask about liking and wanting of the e-cigarette (one item VAS scale with ratings from most disliked sensation imaginable to most liked sensation imaginable with higher values indicating greater liking)</description>
  </primary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Nicotine Use Disorder</condition>
  <arm_group>
    <arm_group_label>Low nicotine, tobacco</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>6 mg nicotine combined with tobacco flavored e-juice</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low nicotine, menthol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>6 mg nicotine combined with menthol flavored e-juice</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low nicotine, strawberry</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>6 mg nicotine combined with strawberry flavored e-juice</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High nicotine, tobacco</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>18 mg nicotine combined with tobacco flavored e-juice</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High nicotine, menthol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>18 mg nicotine combined with menthol flavored e-juice</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hign Nicotine, strawberry</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>18 mg nicotine combined with strawberry flavored e-juice</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nicotine</intervention_name>
    <description>Nicotine level (6 or 18 mg)</description>
    <arm_group_label>High nicotine, menthol</arm_group_label>
    <arm_group_label>High nicotine, tobacco</arm_group_label>
    <arm_group_label>Hign Nicotine, strawberry</arm_group_label>
    <arm_group_label>Low nicotine, menthol</arm_group_label>
    <arm_group_label>Low nicotine, strawberry</arm_group_label>
    <arm_group_label>Low nicotine, tobacco</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Flavor</intervention_name>
    <description>Flavor of e-juice (tobacco, menthol, strawberry)</description>
    <arm_group_label>High nicotine, menthol</arm_group_label>
    <arm_group_label>High nicotine, tobacco</arm_group_label>
    <arm_group_label>Hign Nicotine, strawberry</arm_group_label>
    <arm_group_label>Low nicotine, menthol</arm_group_label>
    <arm_group_label>Low nicotine, strawberry</arm_group_label>
    <arm_group_label>Low nicotine, tobacco</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ages 18-24 years or 35 -50 years

          -  Able to read and write

          -  Smoking &gt; 10 cigarettes or cigars/day

          -  Willing to abstain from regular smoking for 2 weeks and use only e-cigarettes

          -  Not seeking treatment to stop smoking

          -  No regular use of e-cigarettes

        Exclusion Criteria:

          -  Daily use of other drugs including prescribed psychoactive drugs

          -  Any significant current medical or psychiatric condition

          -  Known hypersensitivity to propylene glycol

          -  Pregnant or lactating females
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Asti Jackson, PhD</last_name>
    <phone>203-974-7598</phone>
    <email>asti.jackson@yale.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alissa Goldberg, LMSW</last_name>
    <phone>203-974-7809</phone>
    <email>alissa.goldberg@yale.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CMHC, Substance Abuse Center</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06519</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Asti Jackson, PhD</last_name>
      <phone>203-974-7598</phone>
      <email>asti.jackson@yale.edu</email>
    </contact>
    <contact_backup>
      <last_name>Alissa Goldberg, LMSW</last_name>
      <phone>2039747809</phone>
      <email>alissa.goldberg@yale.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Suchitra Krishnan-Sarin, Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>August 13, 2018</study_first_submitted>
  <study_first_submitted_qc>August 13, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 17, 2018</study_first_posted>
  <last_update_submitted>January 16, 2020</last_update_submitted>
  <last_update_submitted_qc>January 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tobacco Use Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

